Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir

Condition:   Hepatitis C VirusInterventions:   Biological: Peginterferon Lambda-1a;   Biological: Peginterferon Alfa-2a;   Drug: Ribavirin;   Drug: TelaprevirSponsor:   Bristol-Myers SquibbActive, not recruiting - verified February 2014

Source: ClinicalTrials.gov - May 14, 2012 Category: Research Source Type: clinical trials